Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Green Technology Metals: Delivering the Next Lithium Hub in North America September 18, 2025 Investing in Graphene Companies September 18, 2025 New Research on Deep-Sea Mineral Sources Reveals Ecological Importance September 18, 2025